Articles

1. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis

   • Seher Sener
   • Emil Aliyev
   • Seza Ozen

   ORIGINAL ARTICLE 29 April 2024

2. Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort

   • Alexandre Sepriano
   • Sofia Ramiro
   • Walter P. Maksymowych

   ORIGINAL ARTICLE 29 April 2024

   

3. Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era—results from a nationwide study

   • Alper Sarı
   • Hasan Satış
   • Ali Akdoğan

   ORIGINAL ARTICLE 27 April 2024

   

4. Prediction model for developing neuropsychiatric systemic lupus erythematosus in lupus patients

   • Si-Yu Feng
   • Lin-Chong Su
   • Wang-Dong Xu

   Original Article 27 April 2024

   

5. Inflammatory profile in patients with rheumatoid arthritis and sarcopenia

   • Mariel Lozada-Mellado
   • Luis Llorente
   • Lilia Castillo-Martínez

   BRIEF REPORT 26 April 2024

   

6. Adjunct treatment with ozone to enhance therapy of knee osteoarthritis: preliminary results

   • Luigi Valdenassi
   • Marianna Chierchia
   • Marianno Franzini

   BRIEF REPORT 26 April 2024

   

7. Reduced T2*-weighted placental MRI predicts foetal growth restriction in women with chronic rheumatic disease—a Danish explorative study

   • Thea Vestergaard
   • Mette Julsgaard
   • Bodil Ginnerup Pedersen

   ORIGINAL ARTICLE Open access 26 April 2024

   

8. Does pain intensity after total knee arthroplasty depend on somatosensory functioning in knee osteoarthritis patients? A prospective cohort study

   • Sophie Vervullens
   • Lotte Meert
   • Mira Meeus

   ORIGINAL ARTICLE Open access 26 April 2024

   

9. Caregiver burden in families of children with juvenile idiopathic arthritis in India

   • Nikhil C. Gowda
   • Rudrarpan Chatterjee
   • Amita Aggarwal

   ORIGINAL ARTICLE 25 April 2024

   

10. Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases

    • Anna Sheahan
    • Suzanne Anjohrin
    • Victor S. Sloan

    ORIGINAL ARTICLE Open access 25 April 2024

    

11. Combination of Sjögren’s syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature

    • Oksana Andreevna Golovina
    • Anna Vasilievna Torgashina
    • Elena Georgievna Sagina

    CASE BASED REVIEW 23 April 2024

    

12. Two-dimensional speckle-tracking echocardiography in left ventricular systolic function in patients with systemic lupus erythematosus

    • Yuhong Liu
    • Shanshan Yin
    • Hui Zhang

    ORIGINAL ARTICLE 23 April 2024

    

13. The power of us: breaking barriers and bridging the gap of ultrasound in rheumatology to empower a new generation

    • Mario R. Garcia-Pompermayer
    • Sarah G. Ayton
    • Mario Alberto Garza Elizondo

    ORIGINAL ARTICLE 23 April 2024

    

14. Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study

    • Daphne Rivero-Gallegos
    • Mayra Mejía
    • Jorge Rojas-Serrano

    ORIGINAL ARTICLE 20 April 2024

    

15. Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022

    • Geoffrey Littlejohn
    • Nithila Anbumurali
    • Hedley Griffiths

    ORIGINAL ARTICLE Open access 18 April 2024

    

16. Reliability and concurrent validity of 30-s and 5-time sit-to-stand tests in older adults with knee osteoarthritis

    • Lalita Khuna
    • Tussaneeporn Soison
    • Napaporn Tangadulrat

    ORIGINAL ARTICLE 18 April 2024

    

17. CD8 T cell-derived perforin regulates macrophage-mediated inflammation in a murine model of gout

    • Tianqi Wang
    • Chunpan Zhang
    • Yanying Liu

    ORIGINAL ARTICLE 16 April 2024

    

18. Rare combo: moyamoya and lupus in men

    • Dilara Bulut Gökten
    • Murat Gökten
    • Rıdvan Mercan

    CASE BASED REVIEW 16 April 2024

    

19. A more detailed description of study methods could be needed: Comments on “Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis”

    • Zhencheng Zhang
    • Zaixing Yang

    LETTER TO THE EDITOR 15 April 2024

20. Regarding the hypogammaglobulinemia in invasive fungal infection in ANCA‑associated vasculitis

    • Wei Huang
    • Qinggang Zhang
    • Jinlin Liu

    LETTER TO THE EDITOR 15 April 2024

21. Reply to Letter "Regarding the hypogammaglobulinemia in invasive fungal infection in ANCA -associated vasculitis

    • Sahana Baliga
    • Sandeep Yadav
    • C. Balakrishnan

    LETTER TO THE EDITOR 15 April 2024

22. A rebuttal letter as regards: A more detailed description of study methods could be needed—comments on “Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis”

    • Arwa S. Amer
    • Samia M. Abdel Moneam
    • Dalia M. Abd El-Hassib

    LETTER TO THE EDITOR 15 April 2024

    

23. Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors

    • Ayşegül Yetişir
    • Aylin Sariyildiz
    • Ilke Coskun Benlidayi

    ORIGINAL ARTICLE 15 April 2024

    

24. The Juvenile Arthritis Quality of Life Questionnaire in patients with juvenile idiopathic arthritis: Turkish version, validity, and reliability study

    • Yahya Doğan
    • Nur Banu Karaca
    • Seza Özen

    ORIGINAL ARTICLE 15 April 2024

    

25. Characteristics of the oral microbiota in patients with primary Sjögren’s syndrome

    • Yiwen Xie
    • Yu Fan
    • Guohong Zhang

    ORIGINAL ARTICLE 11 April 2024

    

26. Male patients with primary Sjögren’s syndrome have unique clinical manifestations and circulating lymphocyte profiles

    • Huan Liu
    • Jiangshui Yuan
    • Shuguo Wang

    ORIGINAL ARTICLE 11 April 2024

    

27. Elevated serum 25-hydroxyvitamin D: a potential indicator of remission in Takayasu arteritis patients with normal ESR and CRP levels

    • Hua Liao
    • Juan Du
    • Lili Pan

    Original Article 10 April 2024

    

28. Latent class analysis of psychological resilience and influencing factors in patients with rheumatoid arthritis: a cross-sectional survey

    • Jian Zhou
    • Yuqin Gan
    • Zongting Luo

    ORIGINAL ARTICLE 10 April 2024

    

29. Hematological indices in psoriatic enthesopathy: relation to clinical and ultrasound evaluation

    • Arwa S. Amer
    • Ahmed Y. Al Shambaky
    • Amira Khalil Sobih

    ORIGINAL ARTICLE Open access 08 April 2024

    

30. An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients

    • Junyu Liang
    • Liyan Wan
    • Jin Lin

    ORIGINAL ARTICLE Open access 08 April 2024

    

31. Letter to the Editor: “Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis”

    • Tianfei Yu
    • Siyuan Qian
    • Ming Li

    LETTER TO THE EDITOR 06 April 2024 Pages: 1779 - 1781

32. Non-thyroidal disease syndrome in patients with systemic lupus erythematosus: relation to disease inflammatory activity

    • Xue Meng
    • Ang Lv
    • Haiqing Zhang

    ORIGINAL ARTICLE 05 April 2024 Pages: 1551 - 1558

33. Geiser Sign in a patient with rheumatoid arthritis

    • Daniela Oliveira
    • Raquel Miriam Ferreira
    • Carlos Vaz

    CLINICAL IMAGE 04 April 2024 Pages: 1785 - 1786

    

34. Functional capacity, physical activity, and arterial stiffness in patients with systemic sclerosis

    • Aylin Tanriverdi
    • Buse Ozcan Kahraman
    • Sema Savci

    ORIGINAL ARTICLE 04 April 2024 Pages: 1657 - 1664

    

35. Divergent perspectives: exploring the relationships between St. George’s Respiratory Questionnaire and outcome measures in systemic sclerosis–associated interstitial lung disease

    • Enes Basaran
    • Duygu Temiz Karadag
    • Ayse Cefle

    ORIGINAL ARTICLE 04 April 2024 Pages: 1647 - 1656

    

36. Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjögren syndrome

    • Nan Xu
    • Xuanhan Wang
    • Guoqing Li

    ORIGINAL ARTICLE 03 April 2024 Pages: 1683 - 1692

    

37. Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study

    • Kerem Abacar
    • Sema Kaymaz-Tahra
    • Fatma Alibaz-Öner

    ORIGINAL ARTICLE 02 April 2024 Pages: 1571 - 1578

    

38. A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics

    • Ruyu Liang
    • Haojie Xu
    • Yin Su

    Original Article 02 April 2024 Pages: 1541 - 1550

    

39. Gardening/yardwork in people with knee osteoarthritis is not associated with symptom or structural progression over 48 months: data from the Osteoarthritis Initiative

    • Grace H. Lo
    • Julieann C. Patarini
    • Jeffrey B. Driban

    ORIGINAL ARTICLE 01 April 2024 Pages: 1755 - 1762

    

40. Development and validation of a risk prediction model for valve regurgitation in Behçet’s disease

    • Zixian Deng
    • Benhui Liang
    • Jianghua Li

    ORIGINAL ARTICLE 27 March 2024 Pages: 1711 - 1721

    

41. The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjögren’s syndrome

    • Lu Lu
    • Tiantian Dai
    • Guoqing Li

    Original Article 27 March 2024 Pages: 1675 - 1682

    

42. Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores

    • Alix Bird
    • Lauren Oakden-Rayner
    • Lyle J. Palmer

    ORIGINAL ARTICLE Open access 27 March 2024 Pages: 1503 - 1512

    

43. Efficacy and safety of tofacitinib for chronic plaque psoriasis and psoriatic arthritis: a systematic review and meta-analysis of randomized controlled trials

    • Qianqian Dai
    • Yanfeng Zhang
    • Chijin Zhang

    ORIGINAL ARTICLE 22 March 2024 Pages: 1605 - 1613

    

44. How can clinicians enhance self-efficacy beliefs in osteoarthritis? An overview of systematic reviews with meta-analysis

    • Javier Martinez-Calderon
    • Francisco Javier Cano-García
    • Marta Infante-Cano

    REVIEW ARTICLE 22 March 2024 Pages: 1435 - 1446

    

45. Naifold capillaroscopy in mixed connective tissue disease patients

    • Sylwia Ornowska
    • Mariusz Wudarski
    • Marzena Olesińska

    ORIGINAL ARTICLE 21 March 2024 Pages: 1703 - 1709

    

46. Clinical features and risk factors of primary Sjögren’s syndrome complicated with severe pneumonia: a case–control study

    • Bo Cai
    • Zhiliang Guo
    • Xianming Long

    ORIGINAL ARTICLE 21 March 2024 Pages: 1665 - 1674

    

47. Identification of EPSTI1 as a new potential biomarker for SLE based on GEO database

    • Yiying Yang
    • Huali Zhang
    • Muyao Guo

    ORIGINAL ARTICLE 20 March 2024 Pages: 1531 - 1540

    

48. A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus

    • Mengjie Chen
    • Jianxin Tu
    • Li Sun

    ORIGINAL ARTICLE 20 March 2024 Pages: 1521 - 1530

    

49. Raman spectroscopic analysis of joint capsule calcification of the fingers

    • T. L. Jansen
    • M. Janssen
    • T. Niessink

    CLINICAL IMAGE 19 March 2024 Pages: 1783 - 1784

    

50. Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

    • Qi An
    • Rulan Ma
    • Lan He

    ORIGINAL ARTICLE 18 March 2024 Pages: 1491 - 1501